Eupraxia Pharmaceuticals
EPRX • NASDAQ
Eupraxia Pharmaceuticals is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO James A. Helliwell, with a market cap of $193.5M.
CEOJames A. Helliwell
Next Earnings
Upcoming earnings announcement for Eupraxia Pharmaceuticals
Date
Tuesday, May 5, 2026 (in a month)
Timing
After Market Close (6:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.20
Earnings History
Past 6 earnings reports for Eupraxia Pharmaceuticals
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 12, 2026 | Q4 2025 | -$0.37Est: -$0.16 | -131.3% | - | — | — |
| Nov 4, 2025 | Q3 2025 | -$0.19Est: -$0.21 | +9.5% | - | — | — |
| Aug 12, 2025 | Q2 2025 | -$0.26Est: -$0.19 | -36.8% | - | — | — |
| May 6, 2025 | Q1 2025 | -$0.21 | — | — | — | — |
| Mar 20, 2025 | Q4 2024 | -$0.22 | — | - | — | — |
| Nov 7, 2024 | Q3 2024 | -$0.17 | — | - | — | — |